bpc 157 hims Confirmed: The FDA just moved BPC-157 one step closer to compounded access. This could unleash an entirely new revenue stream. $HIMS Hims & Hers Stock Pops
Hims & Hers Stock Pops on FDA Panel's Peptide Recommendation Barron's Hims & Hers stock rises as FDA schedules peptide review BPC 157 Prime Human Labs BPC 157 Rocky Mountain Peptides HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer BPC 157 Alphaceuticals by Dr. Catherine
Pay in 4 interest-free payments of $6.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




